Received Oct 3, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| COVID19 | COVID19 (COVID19 (MODERNA)) | MODERNA | UNK | 3042914 | IM |
Gall bladder surgery; This spontaneous case was reported by a pharmacist and describes the occurrence of GALLBLADDER DISORDER (Gall bladder surgery) in a female patient of an unknown age who received mRNA-1273.712 (SPIKEVAX 2024-2025 PFS) (batch no. 3042914) for COVID-19 prophylaxis. Previously administered products included for COVID-19 prophylaxis: Spikevax NOS (patient probably received more COVID-19 vaccines in 2023 but this was the only information.) in 2023. Past adverse reactions to the above products included No adverse effect with Spikevax NOS. On 24-Sep-2024, the patient received dose of mRNA-1273.712 (SPIKEVAX 2024-2025 PFS) (Intramuscular use) 1 dosage form. On an unknown date, the patient experienced GALLBLADDER DISORDER (Gall bladder surgery). At the time of the report, GALLBLADDER DISORDER (Gall bladder surgery) outcome was unknown. For mRNA-1273.712 (SPIKEVAX 2024-2025 PFS) (Intramuscular use), the reporter did not provide any causality assessments. No concomitant medications were reported. The reporter asked if there was any contraindication to a patient who had just undergone gall bladder surgery a week ago. The reporter mentioned that it had been over 3 months already since the patient had her last COVID-19 vaccine. No treatment medications were reported.